This was defined as a tumor rich in CD8 + T-cells, an IFNγ CTL signature and PD-L1 expression.44 Hence using DC vaccination to increase the pool of antigen-specific CTL is likely to increase responses to anti-PD-1/PDL-1 antibodies. The gene discussed is CD8A; the disease is neoplasm.